Click Here to View VSI Newsletter in Browser


This Newsletter Has Been Generously Sponsored By:

VSI Spring 2019 Newsletter
Bibliography and Sources

Back to Newsletter


Amer AA, Mchepange UO, Gao XH, et al. Hidden victims of childhood vitiligo: impact on parents’ mental health and quality of life. Acta Derm Venereol. 2015 Mar;95(3):322-5.

American Academy of Allergy, Asthma, & Immunology. Atopy Definition.

Cadmus SD, Lundgren AD, Ahmed AM. Therapeutic interventions to lessen the psychosocial effect of vitiligo in children: A review. Pediatr Dermatol. 2018 Jul;35(4):441-447.

Cameron D. What is that Smell?

Cherry K. Erik Erikson’s Stages of Psychosocial Development. Updated April 4, 2019.

Deisinger PJ, Hill TS, English JC. Human Exposure to Naturally Occurring Hydroquinone
J Toxicol Environ Health. 1996 Jan;47(1):31-46. Published online: 30 Nov 2010.

Environment Canada, Health Canada. Proposed Risk Management Approach for 1,4-Benzenediol Hydroquinone
Chemical Abstract Service (CAS) Registry Number: 123-31-9. July 2008.

Esmaeil N, Anaraki SB, Gharagozloo M, Moayedi B. Silymarin impacts on immune system as an immunomodulator: One key for many locks. Int Immunopharmacol. 2017 Sep;50:194-201. Epub 2017 Jun 30.

Eudowe J. Stress and Anxiety Can Be Contagious! Integrative Behavioral Health, LLC. May 9 2017.

Ezzedine K, Silverberg N. A Practical Approach to the Diagnosis and Treatment of Vitiligo in Children.
Pediatrics. 2016 Jul;138(1). Epub 2016 Jun 21.

Gey A, Diallo A, Seneschal J, et al. Autoimmune thyroid disease in vitiligo: multivariate analysis indicates intricate pathomechanisms. Br J Dermatol. 2013 Apr;168(4):756-61.

Halder R, Grimes P, Cowan C et al. Childhood Vitiligo. JAAD. Volume 16, Issue 5, Part 1, Pages 948–954. 1987 May.

Healthline. 7 Science-Based Benefits of Milk Thistle.

Healthline. Hyperosmia.

Jowkar F, Godarzi H, Parvizi MM. Can we consider silymarin as a treatment option for vitiligo? A double-blind controlled randomized clinical trial of phototherapy plus oral Silybum marianum product versus phototherapy alone. J Dermatolog Treat. 2019 Apr 2:1-5. [Epub ahead of print

Krupa Shankar DS, Shashikala K, Madala R. Indian Dermatol Online J. 2012 May-Aug; 3(2): 114–118.

Lee DY, Kim CR, Park JH, Lee JH. The incidence of leukotrichia in segmental vitiligo: implication of poor response to medical treatment. Int J Dermatol. 2011 Aug;50(8):925-7.

Leslie D, Lipsky P, Notkins AL. Autoantibodies as predictors of Disease. J Clin Invest. 2001 Nov 15; 108(10): 1417–1422.

Majid I. Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study. Photodermatol Photoimmunol Photomed. 2010 Oct;26(5):230-4.

Manzoni AP, Weber MB, Nagatomi AR, et al. Assessing depression and anxiety in the caregivers of pediatric patients with chronic skin disorders. An Bras Dermatol. 2013 Nov-Dec; 88(6): 894–899.

Nordlund JJ, Grimes PE, Ortonne JP. The safety of hydroquinone. J Eur Acad Dermatol Venereol. 2006 Aug;20(7):781-7.

Osborn C. Halo Nevus or Mole. Healthline. Medically reviewed 1/8/18.

Saini R. Hyperosmia: Causes, Symptoms, Diagnosis and Treatment.

Shin JY, Kim DW, Park CW, et al. An Educational Program that Contributes to Improved Patient and Parental Understanding of Atopic Dermatitis. Ann Dermatol. 2014 Feb; 26(1): 66–72. Published online 2014 Feb 17.

Siegfried EC, Jaworski JC, Hebert AA. Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice. Am J Clin Dermatol. June 2013;14:163–78.

Silverberg JI, Silverberg NB. Topical tacrolimus is more effective for treatment of vitiligo in patients of skin of color. J Drug Dermatol. 2011 May;10(5):507-10.

Silverberg NB. Recent advances in childhood vitiligo. Clin Dermatol. 2014 Jul-Aug;32(4):524-30. Epub 2014 Feb 28.

Smith MK, Mohammad TF, Hamzavi IH. Assessment of Dietary Supplementation in the Treatment of Vitiligo. The Open Dermatology Journal. 2017 11(1), 12-21.

Spritz RA. Shared Genetic Relationships Underlying Generalized Vitiligo and Autoimmune Thyroid Disease. Thyroid. 2010 Jul; 20(7): 745–754.

Taïeb  A. Vitiligo as an inflammatory skin disorder: a therapeutic perspective. Pigment Cell and Melanoma Research. Volume 25, Issue1. January 2012, pp 9-13. First published: 19 November 2011.

Van Driessche F, Silverberg N. Current Management of Pediatric Vitiligo. Paediatr Drugs. 2015 Aug;17(4):303-13.

Copyright © 2019 Vitiligo Support International Inc. All rights reserved.
Reproduction or republication strictly prohibited without prior written permission

A Vitiligo Support International, Inc. financial statement is available upon written request from the Virginia Office of Consumer Affairs.
Mail requests to: Virginia Department of Agriculture and Consumer Services, Office of Consumer Affairs, P.O. Box 1163, Richmond, Virginia 23218.
Unsubscribe from the original email